• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DAVIS & GECK CARIBE LTD BIOSYN; SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC AC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DAVIS & GECK CARIBE LTD BIOSYN; SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC AC Back to Search Results
Model Number SM-5637
Medical Device Problem Code Detachment of Device or Device Component (2907)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/12/2025
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that during a surgical procedure involving biosyn* 4-0 sutures, the needle detached from the suture while suturing/preparing the suture after the patient incision.The needle did not fall into the patient's cavity.The same issue occurred on the other two sutures from the same batch.An additional new suture was used without issue.No patient complications have been reported as a result of this event.
 
Additional Manufacturer Narrative
D10 concomitant medical product: sm-5637, biosyn* 4-0 und 75cm p12 x12 (lot#d4k3490fy); sm-5637, biosyn* 4-0 und 75cm p12 x12 (lot#d4k3490fy).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Additional Manufacturer Narrative
Correction: b5, d10, e1 (removed initial reporter) d10 concomitant product: sm-5637 sm-5637 biosyn* 4-0 und 75cm p12 x12 (lot#d4k3490fy); sm-5637 sm-5637 biosyn* 4-0 und 75cm p12 x12 (lot#d4k3490fy); sm-5637 sm-5637 biosyn* 4-0 und 75cm p12 x12 (lot#d4l3001fy); sm-5637 sm-5637 biosyn* 4-0 und 75cm p12 x12 (lot#d4l3001fy) medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
It was reported that during a surgical procedure involving biosyn* 4-0 sutures, the needle detached from the suture while suturing/preparing the suture after the patient incision.The needle did not fall into the patient's cavity.The same issue occurred on the second suture from the same batch and three other sutures from a different batch.An additional new suture was used without issue.No patient complications have been reported as a result of this event.
 
Additional Manufacturer Narrative
Additional information: g3, h3, h6.H3 evaluation summary: medtronic conducted an investigation based upon all information received.The device was available for evaluation.The evaluation found no potentially contributing factors and the sample met all related specifications.It was reported that the needle was detached.The reported issue could not be confirmed.The most likely cause could not be identified because no related problem was detected with the device.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOSYN
Common Device Name
SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC AC
Manufacturer (Section D)
DAVIS & GECK CARIBE LTD
zona franca de san isidro
santo domingo 0101
DR  0101
Manufacturer (Section G)
DAVIS & GECK CARIBE LTD
zona franca de san isidro
santo domingo 0101
DR   0101
Manufacturer Contact
justin ellis
8200 coral sea st ne
mounds view, MN 55112
7635265677
MDR Report Key22011788
Report Number9612501-2025-01278
Device Sequence Number12069338
Product Code GAM
UDI-Device Identifier10884521033078
UDI-Public10884521033078
Combination Product (Y/N)N
Initial Reporter CountryCA
PMA/510(K) Number
K000037
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date (Section B) 06/19/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberSM-5637
Device Catalogue NumberSM-5637
Device Lot NumberD4L3001FY
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/07/2025
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/12/2025
Supplement Date Received by Manufacturer05/14/2025
06/10/2025
Initial Report FDA Received Date05/13/2025
Supplement Report FDA Received Date05/15/2025
06/19/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured11/14/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-